Authors: Luck, HJ Du Bois, A Weber, B Pfisterer, J Goupil, A Kuhn, W Barats, JC Blohmer, J Mousseau, M Schroder, W Meier, W Mobus, V Richter, B

Citation: Hj. Luck et al., The integration of anthracyclines in the treatment of advanced ovarian cancer, INT J GYN C, 11, 2001, pp. 34-38

Authors: Wagenaar, HC Pecorelli, S Vergote, I Curran, D Wagener, DJT Kobierska, A Bolis, G ten Bokkel-Huinink, W Lacave, AJ Madronal, C Forni, M de Oliveira, CF Mangioni, C Nooij, MA Goupil, A Kerbrat, P Marth, C Tumolo, S Herben, MG Zanaboni, F Vermorken, JB

Citation: Hc. Wagenaar et al., Phase II study of a combination of cyclophosphamide, adriamycin and cisplatin in advanced Fallopian tube carcinoma - An EORTC Gynecological Cancer Group Study, EUR J GYN O, 22(3), 2001, pp. 187-193

Authors: Delaloge, S Pautier, P Kerbrat, P Castaigne, D Haie-Meder, C Duvillard, P Guivarch, C Goupil, A Borel, C Lhomme, C

Citation: S. Delaloge et al., Neuroendocrine small cell carcinoma of the uterine cervix: What disease? What treatment? Report of ten cases and a review of the literature, CL ONCOL-UK, 12(6), 2000, pp. 357-362

Authors: Montazeri, A Boucaud, M Lokiec, F Pinguet, F Culine, S Deporte-Fety, R Albin, N Laguerre, B Goupil, A Bugat, R Canal, P Chatelut, E

Citation: A. Montazeri et al., Population pharmacokinetics of topotecan: intraindividual variability in total drug, CANC CHEMOT, 46(5), 2000, pp. 375-381

Authors: Joly, F Heron, JF Kerbrat, P Chauvergne, J Rios, M Mayer, F Chinet-Charrot, P Goupil, A Lebrun-Jezekova, D Vennin, D Lhomme, C Mace-Lesec'h, J Crouet, H

Citation: F. Joly et al., High-dose platinum versus standard dose in advanced ovarian carcinoma: A randomized trial from the Gynecologic Cooperative Group of the French Comprehensive Cancer Centers (FNCLCC), GYNECOL ONC, 78(3), 2000, pp. 361-368

Authors: Soulie, P Garrino, C Bensamaine, MA Bekradda, M Brain, E Di Palma, M Goupil, A Misset, JL Cvitkovic, E

Citation: P. Soulie et al., Antitumoral activity of oxaliplatin/cisplatin-based combination therapy incisplatin-refractory germ cell cancer patients, J CANC RES, 125(12), 1999, pp. 707-711